Multinationals Look To M&A As Key China Growth Driver

Mergers and acquisitions have been highlighted as key drivers of growth for pharma companies in China as domestic companies look to expand globally and multinationals attempt to localize.

HONG KONG – Mergers and acquisitions are set to be a key driver of growth for China’s healthcare companies in the near future, as domestic enterprises look both inward and outward to improve their market share and consolidate, while multinationals continue to seek out localization opportunities.

More healthcare companies will likely adopt M&As as a key development strategy over the next three to five years, according...

More from China

More from Focus On Asia